Indication
Mpox vaccination
Mpox vaccination is an active immunization procedure indicated for the pre-exposure prophylaxis or post-exposure prevention of disease caused by the mpox virus, an Orthopoxvirus. Read more about Mpox vaccination
4 drugs 1 manufacturers
Drugs that treat it
Common Mpox vaccination therapies.
JYNNEOS (PF) (smallpox and mpox vaccine, live, nonreplicating/PF)
JYNNEOS (smallpox and mpox vaccine, live, nonreplicating/PF)
JYNNEOS (NATIONAL STOCKPILE) (smallpox and mpox vaccine, live, nonreplicating/PF)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMpox vaccination is an active immunization procedure indicated for the pre-exposure prophylaxis or post-exposure prevention of disease caused by the mpox virus, an Orthopoxvirus.
It is indicated for individuals at elevated risk of infection, including persons with known or suspected recent exposure, populations with behavioral or sexual epidemiological risk factors during outbreaks, and personnel with occupational exposure to orthopoxviruses.
The target condition involves systemic infection following mucosal or cutaneous viral entry, characterized clinically by a prodromal febrile syndrome, prominent lymphadenopathy, and progressive, painful mucocutaneous lesions evolving from maculopapular eruptions to vesicles, pseudo-pustules, and crusts.
Prophylaxis aims to elicit neutralizing cross-protective humoral and cell-mediated immune responses to prevent viral replication, severe cutaneous or visceral involvement, and secondary clinical complications.
- merckmanuals.com
Mpox vaccination is an active immunization procedure indicated for the pre-exposure prophylaxis or post-exposure prevention of disease caused by the mpox virus, an Orthopoxvirus
- fda.gov
Mpox vaccination is an active immunization procedure indicated for the pre-exposure prophylaxis or post-exposure prevention of disease caused by the mpox virus, an Orthopoxvirus Prophylaxis aims to elicit neutralizing cross-protective humoral and cell-mediated immune responses to prevent viral replication, severe cutaneous or visceral involvement, and secondary clinical complications
- cdc.gov
It is indicated for individuals at elevated risk of infection, including persons with known or suspected recent exposure, populations with behavioral or sexual epidemiological risk factors during outbreaks, and personnel with occupational exposure to orthopoxviruses
- cdc.gov
It is indicated for individuals at elevated risk of infection, including persons with known or suspected recent exposure, populations with behavioral or sexual epidemiological risk factors during outbreaks, and personnel with occupational exposure to orthopoxviruses
- scripps.org
The target condition involves systemic infection following mucosal or cutaneous viral entry, characterized clinically by a prodromal febrile syndrome, prominent lymphadenopathy, and progressive, painful mucocutaneous lesions evolving from maculopapular eruptions to vesicles, pseudo-pustules, and crusts
- bioperfectus.com
The target condition involves systemic infection following mucosal or cutaneous viral entry, characterized clinically by a prodromal febrile syndrome, prominent lymphadenopathy, and progressive, painful mucocutaneous lesions evolving from maculopapular eruptions to vesicles, pseudo-pustules, and crusts Prophylaxis aims to elicit neutralizing cross-protective humoral and cell-mediated immune responses to prevent viral replication, severe cutaneous or visceral involvement, and secondary clinical c...
Personalize your experience
Follow Mpox vaccination and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.